XML 39 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Statements of Stockholders' Equity - USD ($)
$ in Thousands
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series A Preferred Stock [Member]
Additional Paid-in Capital [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2015       16,501,500        
Balance at Dec. 31, 2015       $ 16 $ 194,651 $ (131,251) $ (11) $ 63,405
us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised       97,521        
Exercise of common stock options       $ 1 196     197
Issuance of common stock upon ESPP purchase (in shares)       4,538        
Issuance of common stock upon ESPP purchase         11     11
Stock-based compensation expense         3,343     3,343
Unrealized gain on available-for-sale investments             11 11
Net loss           (28,526)   (28,526)
Balance (in shares) at Dec. 31, 2016       16,603,559        
Balance at Dec. 31, 2016       $ 17 198,201 (159,777) 38,441
us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised       74,001        
Exercise of common stock options       108     108
Issuance of common stock upon ESPP purchase (in shares)       100,358        
Issuance of common stock upon ESPP purchase         130     130
Stock-based compensation expense         3,227     3,227
Unrealized gain on available-for-sale investments               (20)
Net loss           (29,964)   (29,964)
Issuance of common stock, net of issuance costs (in shares) 22,000     896,811        
Issuance of common stock, net of issuance costs $ 14,776 $ 6,747 $ 21,523 $ 1 1,287     1,288
Accretion of Series A Convertible Preferred Stock $ 6,747       (6,747)    
Other comprehensive gain/(loss)             (14) (14)
Balance (in shares) at Dec. 31, 2017 22,000     17,674,729        
Balance at Dec. 31, 2017 $ 21,523     $ 18 202,953 (189,741) (14) 34,739
Issuance of common stock upon ESPP purchase            
Stock-based compensation expense     821 821
Net loss     (6,081) (6,081)
Other comprehensive gain/(loss)     10 10
Balance (in shares) at Mar. 31, 2018 22,000     17,674,729        
Balance at Mar. 31, 2018 $ 21,523     $ 18 203,774 (195,822) (4) 29,489
Balance (in shares) at Dec. 31, 2017 22,000     17,674,729        
Balance at Dec. 31, 2017 $ 21,523     $ 18 202,953 (189,741) (14) 34,739
Unrealized gain on available-for-sale investments               19
Net loss               (15,470)
Balance (in shares) at Sep. 30, 2018 22,000     19,221,292        
Balance at Sep. 30, 2018 $ 21,523     $ 19 208,536 (205,211) 4 24,871
Balance (in shares) at Dec. 31, 2017 22,000     17,674,729        
Balance at Dec. 31, 2017 $ 21,523     $ 18 202,953 (189,741) (14) 34,739
Issuance of common stock upon ESPP purchase (in shares)       74,343        
Issuance of common stock upon ESPP purchase         132     132
Stock-based compensation expense         3,429     3,429
Unrealized gain on available-for-sale investments               20
Net loss           (20,729)   (20,729)
Issuance of common stock, net of issuance costs (in shares)     1,494,579        
Issuance of common stock, net of issuance costs       $ 1 2,852     2,853
Other comprehensive gain/(loss)             19 19
Balance (in shares) at Dec. 31, 2018 22,000     19,243,651        
Balance at Dec. 31, 2018 $ 21,523     $ 19 209,366 (210,470) 5 20,443
Balance (in shares) at Mar. 31, 2018 22,000     17,674,729        
Balance at Mar. 31, 2018 $ 21,523     $ 18 203,774 (195,822) (4) 29,489
Issuance of common stock upon ESPP purchase (in shares)     51,984        
Issuance of common stock upon ESPP purchase     84 84
Stock-based compensation expense     922 922
Net loss     (4,879) (4,879)
Other comprehensive gain/(loss)     5 5
Balance (in shares) at Jun. 30, 2018 22,000     17,726,713        
Balance at Jun. 30, 2018 $ 21,523     $ 18 204,780 (200,701) 1 25,621
Issuance of common stock upon ESPP purchase (in shares)            
Issuance of common stock upon ESPP purchase    
Stock-based compensation expense     904 904
Unrealized gain on available-for-sale investments               3
Net loss     (4,510) (4,510)
Issuance of common stock, net of issuance costs (in shares)     1,494,579        
Issuance of common stock, net of issuance costs     $ 1 2,852 2,853
Other comprehensive gain/(loss)     3 3
Balance (in shares) at Sep. 30, 2018 22,000     19,221,292        
Balance at Sep. 30, 2018 $ 21,523     $ 19 208,536 (205,211) 4 24,871
Balance (in shares) at Dec. 31, 2018 22,000     19,243,651        
Balance at Dec. 31, 2018 $ 21,523     $ 19 209,366 (210,470) 5 20,443
Stock-based compensation expense         780     780
Net loss           (6,531)   (6,531)
Other comprehensive gain/(loss)             (2) (2)
Balance (in shares) at Mar. 31, 2019 21,660     19,585,394        
Balance at Mar. 31, 2019 $ 21,183     $ 19 210,486 (217,001) 3 14,690
Balance (in shares) at Dec. 31, 2018 22,000     19,243,651        
Balance at Dec. 31, 2018 $ 21,523     $ 19 209,366 (210,470) 5 $ 20,443
us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised              
Unrealized gain on available-for-sale investments              
Net loss               (13,382)
Balance (in shares) at Sep. 30, 2019 21,660     19,585,394        
Balance at Sep. 30, 2019 $ 21,183     $ 19 210,683 (223,852) 2 8,035
Balance (in shares) at Mar. 31, 2019 21,660     19,585,394        
Balance at Mar. 31, 2019 $ 21,183     $ 19 210,486 (217,001) 3 14,690
Stock-based compensation expense         101     101
Net loss           (5,315)   (5,315)
Other comprehensive gain/(loss)     1 1
Balance (in shares) at Jun. 30, 2019 21,660     19,585,394        
Balance at Jun. 30, 2019 $ 21,183     $ 19 210,587 (222,316) 4 9,477
Stock-based compensation expense     96 96
Unrealized gain on available-for-sale investments              
Net loss     (1,536) (1,536)
Other comprehensive gain/(loss)     (2) (2)
Balance (in shares) at Sep. 30, 2019 21,660     19,585,394        
Balance at Sep. 30, 2019 $ 21,183     $ 19 $ 210,683 $ (223,852) $ 2 $ 8,035